Replies to post #133213 on Biotech Values

[DewDiligence]

PSI-938 was poised to enter late stage testing in 2H/12 pending results in the QUANTUM study. It was not in early development.

To my knowledge, no buyer has ever valued a drug at PSI-938’s development stage as highly as $3B or anything close to that.